News
Zacks.com on MSN19h
Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback